Attachments_0008,_0009,_and_0010.pdf

For the best experience, open this PDF portfolio in

Acrobat X or Adobe Reader X, or later.

Get Adobe Reader Now!

http://www.adobe.com/go/reader

USCENTCOM 021502Z DEC 13 MOD TWELVE TO USCENTCOM INDIVIDUAL

PROTECTION AND INDIVIDUAL-UNIT DEPLOYMENT POLICY

UNCLASSIFIED//

OPERS/ENDURING FREEDOM//

MSGID/GENADMIN/CDRUSCENTCOM/SG/MAR10//

SUBJ/MOD TWELVE TO USCENTCOM INDIVIDUAL PROTECTION AND INDIVIDUAL/UNIT

DEPLOYMENT POLICY//

REF/A/MSG/CDRUSCENTCOM/SG/032024ZOCT2001//

AMPN/ORIGINAL USCINCCENT INDIVIDUAL PROTECTION AND INDIVIDUAL UNIT

DEPLOYMENT POLICY MESSAGE//

REF/B/MSG/CDRUSCENTCOM/SG/021922ZDEC2011//

AMPN/MOD ELEVEN TO USCENTCOM INDIVIDUAL PROTECTION AND UNIT DEPLOYMENT POLICY

MESSAGE. MOD ELEVEN IS NO LONGER VALID AND IS SUPERSEDED BY MOD TWELVE//

REF/C/ DOC/DOD USD (P AND R)/11AUG2006//

AMPN/DODI 6490.03/DEPLOYMENT HEALTH//

REF/D/DOC/DOD USD (P AND R)/03AUG2006

AMPN/DODI 6025.19/INDIVIDUAL MEDICAL READINESS//

REF/E/ DOC/COMDT CG/VARIOUS, AS UPDATED//

AMPN/COMDTINST M6000.1E/MEDICAL MANUAL//

REF/F/ DOC/SECAF/05JUN2006//

AMPN/AFI 48-123/MEDICAL EXAMINATIONS AND STANDARDS, VOLUME 4 - SPECIAL STANDARDS

AND REQUIREMENTS//

REF/G/ DOC/HQDA/14DEC2007//

AMPN/AR 40-501/STANDARDS OF MEDICAL FITNESS//

REF/H/ DOC/BUMED/14JAN2009//

AMPN/NAVMED P-117/MANUAL OF THE MEDICAL DEPARTMENT//

REF/I/DOC/ASD (HA)/20JUN2009//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/REVISED SERVICE GUIDELINES FOR

REPORTABLE MEDICAL EVENTS//

REF/J/DOC/USD (P AND R)/03OCT2005//

AMPN/DODI 3020.41/CONTRACTOR PERSONNEL AUTHORIZED TO ACCOMPANY THE U.S. ARMED

FORCES//

REF/K/ ORD/CFC/010458ZJUL2006//

AMPN/CFC FRAGO 09-1038/CONTRACTOR CARE IN THE USCENTCOM AOR//

REF/L/DOC/USD (P AND R)/23JAN2009//

AMPN/DODD 1401.10/DOD CIVILIAN EXPEDITIONARY WORKFORCE//

REF/M/DOC/ASD (FMP)/11MAR2006//

AMPN/DODI 1100.21/VOLUNTARY SERVICES IN THE DEPARTMENT OF DEFENSE//

REF/N/ DOC/DEPSECDEF/12OCT2006//

AMPN/DEPUTY SECRETARY OF DEFENSE MEMO/ANTHRAX VACCINE IMMUNIZATION PROGRAM//

REF/O/DOC/USD (P AND R)/09FEB2006//

AMPN/UNDER SECRETARY OF DEFENSE MEMO/POLICY GUIDANCE FOR MEDICAL DEFERRAL

PENDING DEPLOYMENT TO THEATERS OF OPERATION//

REF/P/DODI 6490.12/26FEB2013//

MENTAL HEALTH ASSESSMENT FOR SERVICE MEMBERS DEPLOYED IN CONNECTION WITH A

CONTINGENCY OPERATION//

REF/Q/ DOC/DOD USD (P AND R)/ /05FEB2010//

AMPN/DODI 6490.07/DEPLOYMENT-LIMITING MEDICAL CONDITIONS FOR SERVICE MEMBERS

AND DOD CIVILIAN EMPLOYEES//

REF/R/DOC/ASD (HA)/26JUL2012//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/IMPLEMENTATION OF REVISED

DEPARTMENT OF DEFENSE FORMS 2795, 2796 AND 2900//

REF/S/DOC/HQDA/BUMED/SECAF/07OCT2013//

AMPN/AR 40-562, BUMEDINST 6230.15B, AFI 48-110 IP, CG COMDTINST M6230.4G/

IMMUNIZATIONS AND CHEMOPROPHYLAXIS FOR THE PREVENTION OF INFECTIOUS DISEASES//

REF/T/DOC/DEPSECDEF/28JUN2004//

AMPN/DEPUTY SECRETARY OF DEFENSE MEMO/EXPANSION OF FORCE HEALTH PROTECTION

ANTHRAX AND SMALLPOX IMMUNIZATION PROGRAMS FOR DOD PERSONNEL//

REF/U/DOC/USD (P AND R)/22SEP2004//

AMPN/UNDER SECRETARY OF DEFENSE MEMO/EXPANSION OF FORCE HEALTH PROTECTION

ANTHRAX AND SMALLPOX IMMUNIZATION PROGRAMS FOR EMERGENCY-ESSENTIAL AND

EQUIVALENT DEPARTMENT OF DEFENSE CIVILIAN EMPLOYEES//

REF/V/DOC/USD (P AND R)/6DEC2006//

AMPN/UNDER SECRETARY OF DEFENSE MEMO/IMPLEMENTATION OF THE ANTHRAX VACCINE

IMMUNIZATION PROGRAM (AVIP)//

REF/W/DOC/ASD (HA)/01APR2008//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/UPDATE TO CLINICAL POLICY FOR THE

DEPARTMENT OF DEFENSE SMALLPOX VACCINATION PROGRAM//

REF/X/DOC/USD (P AND R)/ 10SEP2007//

AMPN/UNDER SECRETARY OF DEFENSE MEMO/CHANGE IN POLICY FOR PRE-DEPLOYMENT

ADMINISTRATION OF ANTHRAX AND SMALLPOX VACCINES//

REF/Y/DOC/USD (P AND R)/17OCT2006//

AMPN/DODI 6485.01/HUMAN IMMUNODEFICIENCY VIRUS//

REF/Z/DOC/ASD (HA)/14MAR2006//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/POLICY FOR PRE AND POST DEPLOYMENT

SERUM COLLECTION//

REF/AA/DOC/ASD(HA)/29JUL1981//

AMPN/DODI 6465.1/HEMOGLOBIN S AND ERYTHROCYTE GLUCOSE-6-PHOSPHATE

DEHYDROGENASE DEFICIENCY TESTING PROGRAM//

REF/BB/DOC/ASD (HA)/18MAR2003//

AMPN/DODI 5154.30/ARMED FORCES INSTITUTE OF PATHOLOGY OPERATIONS//

REF/CC/DOC/ASD (HA)/18MAY2007//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/UPDATED POLICY FOR PREVENTION OF

ARTHROPOD-BORNE DISEASES AMONG DEPARTMENT OF DEFENSE PERSONNEL DEPLOYED

TO ENDEMIC AREAS//

REF//DD/USD(I)/20MAR2009//

AMPN/DODI 6420.01/NATIONAL CENTER MEDICAL INTELLIGENCE (NCMI)

REF/EE/ASD (HA)/04SEP2009//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/POLICY MEMORANDUM ON THE USE OF

MEFLOQUIN (LARIAM®) IN MALARIA PROPHYLAXIS//

REF/FF/DOC/DOD USD (P AND R)/04JUN2013//

AMPN/DODI 6490.13/COMPREHENSIVE POLICY ON NEUROCOGNITIVE ASSESSMENTS BY THE

MILITARY SERVICES//

REF/GG/DOC/J4/02NOV2007//

AMPN/MCM-0028-07/PROCEDURES FOR DEPLOYMENT HEALTH SURVEILLANCE//

REF/HH/DOC/ASD(HA)/07OCT2013//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/CLINICAL PRACTICE GUIDELINES FOR

DEPLOYMENT LIMITING MENTAL DISORDERS AND PSYCHOTROPIC MEDICATIONS//

REF/II/DOC/ASD (HA)/15OCT2008//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/GUIDANCE FOR CONTAINMENT OF

VARICELLA OUTBREAKS//

REF/JJ/DOC/CC/05JUN2012//

AMPN/CCR 220-1/DEPLOYMENT HEALTH SURVEILLANCE AND FORCE HEALTH PROTECTION//

REF/KK/DOC/CENTCOM/OCT2012//

AMPN/UNITED STATES CENTRAL COMMAND HEALTHCARE INFORMATION SYSTEM USE POLICY//

REF/LL/DOC/ASD (HA)/15APR2013//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/GUIDANCE ON MEDICATIONS FOR THE

PROPHYLAXIS OF MALARIA//

REF/MM/DOC/ASD (HA)/12AUG2013//

AMPN/ASSISTANT SECRETARY OF DEFENSE MEMO/NOTIFICATION FOR HEALTHCARE

PROVIDERS OF MEFLOQUINE BOX WARNING//

REF/NN/DOC/DOD USD (P AND R)/18SEP2012//

AMPN/DODI 6490.11/DOD POLICY GUIDANCE FOR MANAGEMENT OF MILD TRAUMATIC BRAIN

INJURY AND CONCUSSION IN THE DEPLOYED SETTING//

RMKS/1. (U) THIS IS MODIFICATION TWELVE TO USCENTCOM INDIVIDUAL PROTECTION AND

INDIVIDUAL, UNIT DEPLOYMENT POLICY. IN SUMMARY, MODIFICATIONS HAVE BEEN MADE TO

PARAGRAPH 15 FROM MOD ELEVEN, REF B.

1.A. PARAGRAPH 15 REQUIRED NUMEROUS CHANGES; THEREFORE, IT IS BEING

REPUBLISHED IN ITS ENTIRETY. MOD 12 SUPERSEDES ALL PREVIOUS VERSIONS.

1.B. PARAGRAPH 15 OF REF A HAS BEEN TOTALLY REWRITTEN AS FOLLOWS:

15.A. DEFINITIONS.

15.A.1. DEPLOYMENT. FOR MEDICAL PURPOSES, THE DEFINITION OF DEPLOYMENT IS TRAVEL

TO OR THROUGH THE USCENTCOM AREA OF RESPONSIBILITY (AOR), WITH EXPECTED OR

ACTUAL TIME IN COUNTRY (AKA “BOOTS ON GROUND”) FOR A PERIOD OF GREATER THAN 30

DAYS, EXCLUDING SHIPBOARD OPERATIONS, AS DEFINED IN REF C.

15.A.2. TEMPORARY DUTY (TDY). MISSIONS WITH TIME IN COUNTRY (BOOTS ON GROUND) OF

30 DAYS OR LESS,

15.A.3. PERMANENT CHANGE OF STATION (PCS). PCS PERSONNEL, INCLUDING EMBASSY

PERSONNEL, WILL COORDINATE WITH THEIR RESPECTIVE SERVICE COMPONENT MEDICAL

PERSONNEL FOR MEDICAL GUIDANCE AND REQUIREMENTS FOR PCS TO SPECIFIC

COUNTRIES IN THE USCENTCOM AOR. AUTHORIZED DEPENDENTS MUST PROCESS THROUGH

THE EXCEPTIONAL FAMILY MEMBER PROGRAM (EFMP) AND COMPLY WITH HOST NATION

IMMUNIZATION AND MEDICAL SCREENING REQUIREMENTS. WHILE MOD 12 IN ITS ENTIRITY

DOES NOT APPLY TO PCS PERSONNEL, CERTAIN PORTIONS OF MOD 12 WILL APPLY AS

DELINIATED IN TAB B.

15.A.4. SHIPBOARD PERSONNEL. ALL SHIPBOARD PERSONNEL WHO DEPLOY INTO THE AOR

MUST HAVE CURRENT SEA DUTY SCREENING, REMAIN FULLY MEDICALLY READY FOLLOWING

ANNUAL PERIODIC HEALTH ASSESSMENT (PHA), BUT DO NOT NECESSARILY REQUIRE

DEPLOYMENT HEALTH ASSESSMENT IN 15.H – UNLESS ENTERING A COUNTRY WITH ACTIVE

COMBAT FOR GREATER THAN 30 DAYS.

15.B. APPLICABILITY. THIS MOD APPLIES TO MILITARY PERSONNEL, DOD CIVILIANS, DOD

CONTRACTORS, DOD SUB-CONTRACTORS, VOLUNTEERS AND THIRD COUNTRY NATIONALS

(TCN) TRAVELING OR DEPLOYING TO THE CENTCOM AOR AND WORKING UNDER THE

AUSPICES OF THE DOD. LOCAL NATIONALS SHOULD MEET THE MINIMAL MEDICAL STANDARDS

ADDRESSED IN SECTION 15.C.1.F.

15.C. MEDICAL DEPLOYABILITY. DEPLOYED HEALTH SERVICE SUPPORT INFRASTRUCTURE

PROVIDES ONLY LIMITED MEDICAL CARE. ALL PERSONNEL (UNIFORMED SERVICE MEMBERS,

GOVERNMENT CIVILIAN EMPLOYEES, VOLUNTEERS, DOD CONTRACTOR EMPLOYEES)

TRAVELING TO THEATER MUST BE MEDICALLY, DENTALLY AND PSYCHOLOGICALLY FIT FOR

DEPLOYMENT. INDIVIDUALS DEEMED UNABLE TO COMPLY WITH CENTCOM DEPLOYMENT

REQUIREMENTS WILL BE DISQUALIFIED FOR DEPLOYMENT IAW SERVICE POLICY AND MOD 12.

PERSONNEL FOUND NON-DEPLOYABLE WHILE OUTSIDE OF THE CENTCOM AOR WILL NOT

ENTER OR RE-ENTER THE THEATER. FOR EXAMPLE, ANY PERSONNEL WHO BECOME

MEDICALLY NON-DEPLOYABLE WHILE IN ANY LEAVE OR OTHER STATUS WILL NOT RE-ENTER

THE AOR UNTIL THE NON-DEPLOYABLE CONDITION IS CLEARED OR A WAIVER FOR THE NON-

DEPLOYABLE CONDITION IS APPROVED BY A CENTCOM WAIVER AUTHORITY. SEE REF D, E, F, G

AND H. DOD CIVILIAN EMPLOYEES ARE COVERED BY THE REHABILITATION ACT OF 1973. AS

SUCH, AN APPARENTLY DISQUALIFYING MEDICAL CONDITION NEVERTHELESS REQUIRES THAT

AN INDIVIDUALIZED ASSESSMENT BE MADE TO DETERMINE WHETHER THE EMPLOYEE CAN

PERFORM THE ESSENTIAL FUNCTIONS OF HIS/HER POSITION IN THE DEPLOYED

ENVIRONMENT, WITH OR WITHOUT A REASONABLE ACCOMMODATION, WITHOUT CAUSING

UNDUE HARDSHIP. IN EVALUATING UNDUE HARDSHIP, THE NATURE OF THE ACCOMODATION

AND THE LOCATION OF THE DEPLOYMENT MUST BE CONSIDERED. FURTHER, THE

EMPLOYEE’S MEDICAL CONDITION MUST NOT POSE A SUBSTANTIAL RISK OF SIGNIFICANT

HARM TO THE EMPLOYEE OR OTHERS WHEN TAKING INTO ACCOUNT THE CONDITIONS OF THE

RELEVANT DEPLOYED ENVIRONMENT. SEE REF Q. THE FINAL AUTHORITY OF WHO MAY

DEPLOY TO THE CENTCOM AOR RESTS WITH THE CENTCOM SURGEON AND/OR THE SERVICE

COMPONENT SURGEON’S WAIVER AUTHORITY, NOT THE INDIVIDUAL’S MEDICAL EVALUATING

ENTITY OR DEPLOYING PLATFORM.

15.C.1. MEDICAL FITNESS, INITIAL AND ANNUAL SCREENING.

15.C.1.A. MEDICAL READINESS PROCESSING. THE MEDICAL SECTION OF THE DEPLOYMENT

SCREENING SITE MAY PUBLISH GUIDANCE, IAW MOD12 AND SERVICE STANDARDS, TO ASSIST

IN DETERMINING MEDICAL DEPLOYMENT FITNESS. DEPLOYING PERSONNEL WITH

POTENTIALLY DISQUALIFYING MEDICAL CONDITIONS NEED TO MEET THE FOLLOWING TWO

CRITERIA FOR DEPLOYMENT: AN EVALUATION BY A PROVIDER TO DETERMINE IF THEY CAN

SAFELY DEPLOY AND AN APPROVED WAIVER BY THE COMPONENT SURGEON OR CENTCOM

SURGEON FOR THE POTENTIALLY DISQUALIFYING MEDICAL CONDITION(S).

15.C.1.B. FITNESS INCLUDES, BUT IS NOT LIMITED TO, THE ABILITY TO ACCOMPLISH THE

TASKS AND DUTIES UNIQUE TO A PARTICULAR OPERATION AND THE ABILITY TO TOLERATE THE

ENVIRONMENTAL AND OPERATIONAL CONDITIONS OF THE DEPLOYED LOCATION. MINIMUM

STANDARDS OF FITNESS INCLUDE, BUT ARE NOT LIMITED TO, THE ABILITY TO WEAR

BALLISTIC, RESPIRATORY, CHEMICAL AND BIOLOGICAL PERSONAL PROTECTIVE EQUIPMENT,

USE OF REQUIRED PROPHYLACTIC MEDICATIONS AND THE ABILITY TO INGRESS/EGRESS IN

EMERGENCY SITUATIONS WITH MINIMAL RISK TO THEMSELVES OR OTHERS.

15.C.1.C. EXAMINATION INTERVALS. AN EXAMINATION WITH ALL MEDICAL ISSUES AND

REQUIREMENTS ADDRESSED WILL REMAIN VALID FOR A MAXIMUM OF 15 MONTHS FROM THE

DATE OF THE PHYSICAL. SEE TAB A AND REF D, J, K, L AND M FOR FURTHER GUIDANCE. THIS

ALLOWS FOR EXAMINATION TO BE VALID FOR UP TO 90 DAYS BEFORE THE DEPLOYMENT

DATE. ONCE A DEPLOYMENT BEGINS, THE EXAMINATION WILL ONLY BE GOOD FOR A MAXIMUM

OF 12 MONTHS. GOVERNMENT CIVILIAN EMPLOYEES, VOLUNTEERS, AND DOD CONTRACTOR

PERSONNEL, WHO DEPLOY FOR MULTIPLE TOURS OF MORE THAN 12 MONTHS TOTAL, MUST

BE RE-EVALUATED FOR FITNESS TO STAY DEPLOYED. ANNUAL IN-THEATER RESCREENING

MAY BE FOCUSED ON HEALTH CHANGES, VACCINATION CURRENCY AND MONITORING OF

EXISTING CONDITIONS, BUT SHOULD CONTINUE TO MEET ALL MEDICAL GUIDANCE AS

PRESCRIBED IN MOD 12. IF INDIVIDUALS ARE UNABLE TO ADEQUATELY COMPLETE THEIR

MEDICAL SCREENING EVALUATION IN THE AOR, THEY SHOULD BE REDEPLOYED TO

ACCOMPLISH THIS YEARLY REQUIREMENT. PERIODIC HEALTH SURVEILLANCE

REQUIREMENTS AND PRESCRIPTION NEEDS ASSESSMENTS SHOULD BE RECENT ENOUGH SO

AS TO REMAIN CURRENT THROUGH THE DEPLOYMENT PERIOD.

15.C.1.D. SPECIALIZED GOVERNMENT CIVILIAN EMPLOYEES WHO MUST MEET SPECIFIC

PHYSICAL STANDARDS (E.G., FIREFIGHTERS, SECURITY GUARDS AND POLICE, AVIATORS,

AVIATION CREW MEMBERS AND AIR TRAFFIC CONTROLLERS, DIVERS, MARINE CRAFT

OPERATORS AND COMMERCIAL DRIVERS) MUST MEET THOSE STANDARDS WITHOUT

EXCEPTION, IN ADDITION TO BEING FOUND FIT FOR THE SPECIFIC DEPLOYMENT BY A MEDICAL

AND DENTAL EVALUATION PRIOR TO DEPLOYMENT IAW MOD 12. CERTIFICATIONS WILL

REMAIN VALID THROUGHOUT THE ENTIRETY OF THE DEPLOYMENT. IF CERTIFICATIONS WILL

EXPIRE DURING THE DEPLOYMENT, IT IS UP TO THE INDIVIDUAL TO PLAN FOR AND RECERTIFY

THEIR RESPECTIVE REQUIREMENTS (I.E. MID TOUR LEAVE, ETC.).

15.C.1.E. DOD CONTRACTOR EMPLOYEES. MUST MEET SIMILAR STANDARDS OF FITNESS AS

OTHER MILITARY AND DOD CIVILIAN PERSONNEL AND IT MUST BE DOCUMENTED THEY ARE FIT

FOR THE PERFORMANCE OF THEIR DUTIES WITHOUT LIMITATIONS BY A MEDICAL AND DENTAL

EVALUATION PRIOR TO DEPLOYMENT IAW MOD 12. CONTRACTORS MUST COMPLY WITH REF J

AND SPECIFICALLY ENCLOSURE 3 FOR MEDICAL REQUIREMENTS AND EVALUATIONS SHOULD

BE COMPLETE PRIOR TO ARRIVAL AT THE DEPLOYMENT PLATFORM. ENSURE COMPLIANCE

WITH IMMUNIZATION, DNA AND PANOGRAPH REQUIREMENTS. PREDEPLOYMENT AND/OR

TRAVEL MEDICINE SERVICES FOR CONTRACTOR EMPLOYEES, INCLUDING IMMUNIZATIONS,

EVALUATION OF FITNESS AND ANNUAL SCREENING. THESE ITEMS ARE THE RESPONSIBILITY

OF THE CONTRACTING AGENCY PER THE CONTRACTUAL REQUIREMENTS. QUESTIONS

SHOULD BE SUBMITTED TO THE SUPPORTED COMMAND'S CONTRACTING AND MEDICAL

AUTHORITY. SEE TAB A AND REF J FOR FURTHER GUIDANCE.

15.C.1.E.1. ALL CONTRACTING AGENCIES ARE RESPONSIBLE FOR PROVIDING THE

APPROPRIATE LEVEL OF MEDICAL SCREENING FOR THEIR EMPLOYEES BASED ON THE JOB

THEY ARE HIRED TO PERFORM. THE SCREENING MUST BE COMPLETED BY A LICENSED

MEDICAL PROVIDER (LICENCED IN A COUNTRY WITH OVERSIGHT AND ACCOUNTABILITY OF

THE MEDICAL PROFESSION) AND A COPY OF THE COMPLETED MEDICAL SCREENING

DOCUMENTATION, IN ENGLISH, MUST BE MAINTAINED BY THE CONTRACTOR. SUCH

DOCUMENTATION MAY BE REQUESTED BY BASE OPERATIONS CENTER PERSONNEL PRIOR TO

ISSUANCE OF ACCESS BADGES AS WELL AS BY MEDICAL PERSONNEL FOR COMPLIANCE

REVIEWS. INSTALLATION COMMANDERS, IN CONCERT WITH THEIR LOCAL MEDICAL ASSETS

AND CONTRACTING REPRESENTATIVES, MAY CONDUCT QUALITY ASSURANCE AUDITS TO

VERIFY THE VALIDITY OF MEDICAL SCREENINGS.

15.C.1.E.2. CONTRACTOR EXPENSE. IAW REF J, CONTRACTORS WILL PROVIDE THE

PREDEPLOYMENT MEDICAL AND DENTAL EVALUATIONS, AND ANNUAL IN THEATER

RESCREENING WILL BE AT CONTRACTOR EXPENSE. THESE EVALUATIONS FOR DOD

CONTRACTORS SHALL OCCUR PRIOR TO ARRIVAL AT THE DEPLOYMENT CENTER/PLATFORM.

ALL REQUIRED IMMUNIZATIONS OUTLINED IN THE FOREIGN CLEARANCE GUIDE

(HTTPS://WWW.FCG.PENTAGON.MIL) FOR THE COUNTRIES TO BE VISITED, AS WELL AS THOSE

OUTLINED IN PARAGRAPH 15.F. OF THIS MOD, WILL BE DONE AT CONTRACTOR EXPENSE. A

DISQUALIFYING MEDICAL CONDITION, AS DETERMINED BY AN IN-THEATER COMPETENT

MEDICAL AUTHORITY, WILL BE IMMEDIATELY REPORTED TO THE CONTRACTOR EMPLOYEE'S

CONTRACTING OFFICER WITH A RECOMMENDATION THAT THE CONTRACTOR BE IMMEDIATELY

REDEPLOYED AND REPLACED AT CONTRACTOR EXPENSE. ALL THE ABOVE EXPENSES WILL

BE COVERED BY THE CONTRACTOR UNLESS OTHERWISE SPECIFIED IN THE CONTRACT.

https://www.fcg.pentagon.mil/

15.C.1.E.3. MILITARY EXPENSE. THE MILITARY WILL PROVIDE THEATER SPECIFIC ANTHRAX

AND SMALLPOX VACCINES. SEE REF C, J AND N.

15.C.1.F. LN AND TCN EMPLOYEES. MINIMUM SCREENING REQUIREMENTS FOR LN AND TCN

EMPLOYEES FOLLOW.

15.C.1.F.1. PRE-EMPLOYMENT AND ANNUAL MEDICAL SCREENING OF LN AND TCN EMPLOYEES

IS NOT TO BE PERFORMED IN MILITARY MTFS. LOCAL CONTRACTING AGENCIES MUST KEEP

DOCUMENTATION IAW PARA. 15.C.1.E.1.

15.C.1.F.2. ALL LN AND TCN EMPLOYEES WHOSE JOB REQUIRES CLOSE OR FREQUENT

CONTACT WITH NON-LN/TCN PERSONNEL (E.G., DINING FACILITY WORKERS, SECURITY

PERSONNEL, INTERPRETERS, ETC.) MUST BE SCREENED FOR TUBERCULOSIS (TB) USING AN

ANNUAL SYMPTOM SCREEN LOCATED AT

HTTP://APPS.WHO.INT/IRIS/BITSTREAM/10665/84971/1/9789241548601_ENG.PDF (ANNEX III, ALGORITHM 1C, PAGE 115). A TUBERCULIN SKIN TEST (TST) IS UNRELIABLE AS A STAND-ALONE

SCREENING TEST FOR TB DISEASE IN LN/TCN PERSONNEL AND SHOULD NOT BE USED.

SPECIFIC QUESTIONS REGARDING APPROPRIATE SCREENING OF DETAINEES, PRISON

GUARDS AND OTHER HIGHER RISK POPULATIONS SHOULD BE REFERRED TO THE THEATER

PREVENTIVE MEDICINE CONSULTANT THROUGH THE UNITS MEDICAL PERSONNEL.

15.C.1.F.3. LN AND TCN EMPLOYEES INVOLVED IN FOOD SERVICE, WATER AND ICE

PRODUCTION MUST BE SCREENED ANNUALLY FOR SIGNS AND SYMPTOMS OF INFECTIOUS

DISEASES. CONTRACTORS MUST ENSURE EMPLOYEES RECEIVE TYPHOID AND HEPATITIS A

VACCINATIONS AND THIS INFORMATION MUST BE DOCUMENTED IN THE EMPLOYEES MEDICAL

RECORD / SCREENING DOCUMENTATION.

15.C.1.F.4. FURTHER GUIDANCE OF MEDICAL SUITABILITY REGARDING FORCE HEALTH

PROTECTION MAY BE PROVIDED BY THE LOCAL TASK FORCE COMMANDER OR EQUIVALENT IN

CONSULTATION WITH THEIR MILITARY MEDICAL ASSETS.

15.C.2. UNFIT PERSONNEL. CASES OF IN-THEATER/DEPLOYED PERSONNEL IDENTIFIED AS

UNFIT IAW THIS MOD 12, DUE TO CONDITIONS THAT EXISTED PRIOR TO DEPLOYMENT, WILL BE

FORWARDED TO THE COMPONENT SURGEON (THE APPROPRIATE SURGEON WHO WOULD

HAVE RECEIVED A WAIVER REQUEST HAD ONE BEEN SUBMITTED) FOR INVESTIGATION AND

POTENTIAL REDEPLOYMENT DETERMINATION. FINDINGS/ACTIONS WILL BE FORWARDED

AFTER COMPLETION TO THE CENTCOM SURGEON AT EMAIL: CCSG-WAIVER@CENTCOM.MIL. IN

ORDER TO COMPLY WITH REPORTABLE MEDICAL EVENT (RME) REPORTING CRITERIA AS

REQUIRED. SEE REF I.

15.C.3. MEDICAL WAIVERS.

15.C.3.A. MEDICAL WAIVER APPROVAL AUTHORITY.

15.C.3.A.1. MEDICAL WAIVER APPROVAL AUTHORITY LIES AT THE COMBATANT COMMAND

SURGEON LEVEL IAW REF S, O AND Q.

15.C.3.A.2. DELEGATION TO COMPONENTS. WAIVER AUTHORITY IS DELEGATED TO THE

USCENTCOM COMPONENT SURGEONS FOR ALL DEPLOYING PERSONNEL WITHIN THEIR

RESPECTIVE COMPONENT FOR ALL HEALTH CONDITIONS (ARMY, ARMY COMPONENT

AGENCIES, AND ARMY CONTRACTORS WILL FIRST CONSULT WITH THE ARCENT SURGEON; AF

AND AF ASSOCIATED PERSONNEL WITH THE AFCENT SURGEON, ETC.). CONTRACTORS AND

SUB CONTRACTORS RESPECTIVE SERVICE AFFILIATION IS DETERMINED BY THE

‘CONTRACTOR ISSUING AGENCY’ BLOCK ON THEIR ‘LETTER OF AUTHORIZATION’ AND WAIVERS

SHOULD BE SENT TO THE APPROPRIATE SERVICE COMPONENT WAIVER AUTHORITY. SEE

SECTION 15.C.3.C. IF A SERVICE WISHES TO DEPLOY A MEMBER WHO IS DETERMINED UNFIT

FOR DEPLOYMENT, THE SERVICE MUST OBTAIN A WAIVER FROM THE CENTCOM COMMAND

SURGEON OR CENTCOM COMPONENT SURGEON AS OUTLINED ABOVE. BEHAVIORAL HEALTH

WAIVERS WILL INITIALLY BE SENT TO THE RESPECTIVE SERVICE COMPONENT, BUT THE FINAL http://apps.who.int/IRIS/BITSTREAM/10665/84971/1/9789241548601_ENG.PDF mailto:CCSG-WAIVER@CENTCOM.MIL

DETERMINATION FOR APPROVAL STILL RESIDES WITH THE CENTCOM SURGEON. SENDING

UNIT COMMANDERS MUST OBTAIN A MEDICAL WAIVER AND ARE NOT AUTHORIZED TO

OVERRIDE THE MEDICAL DEPLOYABILITY DETERMINATION. UNLIKE THE MILITARY PROFILE

SYSTEM, UNIT COMMANDERS CANNOT OVERRIDE THE DEPLOYABILITY WAIVER AUTHORITY.

15.C.3.A.3. EXCEPT IN THE CASE OF DOD CIVILIAN EMPLOYEES WHO ARE COVERED BY THE

REHABILITATION ACT OF 1973, AN INDIVIDUAL MAY BE DENIED DEPLOYMENT BY THE LOCAL

MEDICAL AUTHORITY OR CHAIN OF COMMAND. AN INDIVIDUALIZED ASSESSMENT IS STILL

REQUIRED FOR DOD. SEE PARA. 15.C AND REF Q. AUTHORITY TO APPROVE DEPLOYMENT OF

ANY PERSON (UNIFORMED OR CIVILIAN) WITH APPARENTLY DISQUALIFYING MEDICAL

CONDITIONS OUTLINED IN THIS MODIFICATION AND THE ACCOMPANYING AMPLIFICATION (TAB

A) LIES SOLELY WITH THE CENTCOM SURGEON AND THE CENTCOM SERVICE COMPONENT

SURGEONS WHO HAVE BEEN DELEGATED THIS AUTHORITY BY THE CENTCOM SURGEON.

THEREFORE, IF THE LOCAL COMMAND SUPPORTS THE DEPLOYMENT OF A PERSON WITH AN

APPARENTLY DISQUALIFYING CONDITION AS OUTLINED IN THIS MODIFICATION AND

AMPLIFICATION, A WAIVER REQUEST MUST STILL BE SUBMITTED TO, AND APPROVED BY, THE

APPROPRIATE CENTCOM WAIVER AUTHORITY BEFORE THAT PERSON IS DEPLOYABLE.

15.C.3.A.4. ALL ADJUDICATING SURGEONS WILL MAINTAIN A WAIVER DATABASE AND RECORD

ALL WAIVER REQUESTS.

15.C.3.A.5. THE ADJUDICATING SURGEON MAY CONSIDER CONSULTING THE RECEIVING

MEDICAL AUTHORITY WITH ANY QUESTIONS REGARDING THE DEPLOYABILITY OF THE SERVICE

MEMBER, CIVILIAN OR CONTRACTOR. ADJUDICATION MAY ACCOUNT FOR SPECIFIC MEDICAL

SUPPORT CAPABILITIES IN THE LOCAL REGION OF THE AOR. THE COMPONENT SURGEON WILL

RETURN THE SIGNED WAIVER FORM TO THE REQUEST ORIGINATOR FOR INCLUSION IN THE

PATIENT'S DEPLOYMENT MEDICAL RECORD AND THE ELECTRONIC MEDICAL RECORD (EMR).

15.C.3.B. WAIVER PROCESS. IF A MEDICAL WAIVER IS DESIRED, LOCAL MEDICAL PERSONNEL

WILL INFORM THE NON-DEPLOYABLE INDIVIDUAL AND THE UNIT COMMAND/SUPERVISOR

ABOUT THE WAIVER PROCESS AS FOLLOWS.

15.C.3.B.1. AUTHORIZED AGENTS (LOCAL MEDICAL PROVIDER, COMMANDER/SUPERVISOR,

REPRESENTATIVE OR INDIVIDUAL MEMBER) WILL FORWARD A MEDICAL WAIVER REQUEST

FORM (TAB C), TO BE ADJUDICATED BY THE APPROPRIATE SURGEON IAW PARAGRAPH

15.C.3.C. THE CASE SUMMARY PORTION OF THE WAIVER SHOULD INCLUDE A SYNOPSIS OF

THE CONCERNING CONDITION(S) AND ALL SUPPORTING DOCUMENTATION TO INCLUDE THE

PROVIDERS ASSESSMENT OF ABILITY TO DEPLOY.

15.C.3.B.2. DOCUMENTED DISAPPROVALS FOR VALID CONDITIONS ARE NECESSARY AND

SHOULD NOT BE GIVEN TELEPHONICALLY.

15.C.3.B.3. A CENTCOM WAIVER DOES NOT PRECLUDE THE NEED FOR A SERVICE-SPECIFIC

PSYCHOTROPIC MEDICATION SMALL ARMS WAIVER (E.G., US NAVY SMALL ARMS WAIVER).

15.C.3.B.4. WAIVERS FOR NON-SERVICE AFFILIATED PERSONNEL. THE CENTCOM SURGEON IS

THE WAIVER AUTHORITY FOR DOD CIVILIANS, CONTRACTORS AND ORGANIZATIONS SUCH AS

DEFENSE INTELLIGENCE AGENCY AND AMERICAN RED CROSS, ETC, WHO ARE NOT DIRECTLY

ASSOCIATED WITH A PARTICULAR CENTCOM COMPONENT.

15.C.3.B.5. APPEAL PROCESS. IF THE SENDING UNIT DISAGREES WITH THE COMPONENT

SURGEON’S DECISION, AN APPEAL MAY BE SUBMITTED TO THE CENTCOM SURGEON. IF THE

DISAGREEMENT IS WITH THE CENTCOM SURGEON’S DECISION, AN APPEAL MAY BE

SUBMITTED THROUGH THE CHAIN OF COMMAND TO THE CENTCOM CHIEF OF STAFF.

15.C.3.B.6. WAIVERS ARE APPROVED FOR A MAXIMUM OF 12 MONTHS OR FOR THE

TIMEFRAME SPECIFIED ON THE WAIVER (TAB B). WAIVER COVERAGE BEGINS ON THE DATE OF

THE INITIAL DEPLOYMENT AND REMAINS IN EFFECT FOR EITHER THE TIME PERIOD SPECIFIED

ON THE WAIVER, OR A MAXIMUM TIME OF 12 MONTHS.

15.C.3.C. CONTACTS FOR WAIVERS

15.C.3.C.1. CENTCOM SURGEON. CCSG-WAIVER@CENTCOM.MIL;

CML: 813.529.0345; DSN: 312.529.0345

15.C.3.C.2. AFCENT SURGEON. USCENTAFSG.ORGBOX@AFCENT.AF.MIL;

CML: 803.895.1339; DSN: 312.965.1399 / 4380

15.C.3.C.3. ARCENT SURGEON. USARMY.SHAW.USARCENT.MBX.SURG-WAIVER@MAIL.MIL;

CML: 803.885.7946; DSN: 312.889.7946

15.C.3.C.4. MARCENT SURGEON. FORCE.SURGEON@MARCENT.USMC.MIL;

CML: 813.827.7175; DSN: 312.651.7175

15.C.3.C.5. NAVCENT SURGEON. CUSNC.MEDWAIVERS@ME.NAVY.MIL;

CML: 011.973.1785.4032; DSN: 318.439.4032

15.C.3.C.6. SOCCENT SURGEON. SOCCENT.SG@soccent.centcom.mil;

CML: 813.828.4351; DSN: 312.968.4351

15.D. PHARMACY.

15.D.1. SUPPLY. PERSONNEL WHO REQUIRE MEDICATION AND WHO ARE DEPLOYING TO THE

CENTCOM AOR WILL DEPLOY WITH NO LESS THAN A 180 DAY SUPPLY (OR APPROPRIATE

AMOUNT FOR SHORTER DEPLOYMENTS) OF THEIR MAINTENANCE MEDICATIONS WITH

ARRANGEMENTS TO OBTAIN A SUFFICIENT SUPPLY TO COVER THE REMAINDER OF THE

DEPLOYMENT USING A FOLLOW-ON REFILL PRESCRIPTION. TRICARE ELIGIBLE PERSONNEL

WILL HAVE A FOLLOW-ON REFILL PRESCRIPTION ENTERED INTO THE TRICARE MAIL ORDER

PHARMACY (TMOP) PER THE DEPLOYMENT PRESCRIPTION PROGRAM IAW REF Q.

15.D.2. EXCEPTIONS. EXCEPTIONS TO THE 180 DAY PRESCRIPTION QUANTITY REQUIREMENT

INCLUDE:

15.D.2.A. PERSONNEL REQUIRING MALARIA CHEMOPROPHYLACTIC MEDICATIONS (E.G.,

DOXYCYCLINE, ATOVAQUONE/PROGUANIL, ETC.) WILL DEPLOY WITH EITHER ENOUGH

MEDICATION FOR THEIR ENTIRE DEPLOYMENT OR WITH ENOUGH TO COVER APPROXIMATELY

HALF OF THE DEPLOYMENT WITH PLANS TO RECEIVE THE REMAINDER OF THEIR MEDICATION

IN THEATER (EXCLUDING PRIMAQUINE FOR TERMINAL PROPHYLAXIS) BASED ON UNIT

PREFERENCE. UNITS WILL DISTRIBUTE TERMINAL PROPHYLAXIS UPON REDEPLOYMENT. THE

DEPLOYMENT PERIOD WILL BE CONSIDERED TO INCLUDE AN ADDITIONAL 28 DAYS AFTER

LEAVING THE MALARIA RISK AREA (FOR DOXYCYCLINE) OR 7 DAYS (FOR MALARONE) TO

ACCOUNT FOR REQUIRED PRIMARY PROPHYLAXIS. TERMINAL PROPHYLAXIS WITH

PRIMAQUINE FOR 14 DAYS SHOULD BEGIN ONCE THE INDIVIDUAL MEMBER HAS LEFT THE

AREA OF MALARIA RISK.

15.D.2.B. PSYCHOTROPIC MEDICATION MAY BE DISPENSED FOR UP TO A 180 DAY SUPPLY

WITH NO REFILL.

15.D.2.B.1. IF REQUIRED, THE PROVIDER MAY PRESCRIBE A LIMITED QUANTITY (I.E., AT LEAST

A 90 DAY SUPPLY) WITH NO REFILLS TO FACILITATE CLINICAL FOLLOW-UP IN THEATER.

15.D.2.B.2. PSYCHOTROPIC MEDICATIONS AUTHORIZED FOR UP TO A 180 DAYS SUPPLY

INCLUDE, BUT ARE NOT LIMITED TO; ANTI-DEPRESSANTS, ANTI-ANXIETY (NON CONTROLLED

SUBSTANCES), NON-CLASS 2 (CII) STIMULANTS AND ANTI-SEIZURE MEDICATIONS USED FOR

MOOD DISORDERS. THIS TERM ALSO ENCOMPASSES THE GENERIC EQUIVALENTS OF THE

ABOVE MEDICATION CATEGORIES WHEN USED FOR NON-PSYCHOTROPIC INDICATIONS.

15.D.2.C. ALL CONTROLLED SUBSTANCES WITH THE POTENTIAL FOR DIVERSION AND ABUSE

AND ANTIPSYCHOTICS (TO INCLUDE QUETIAPINE (SEROQUEL)) ARE LIMITED TO A 90 DAY

SUPPLY WITH NO REFILLS. AN APPROVED WAIVER MUST BE OBTAINED FROM THE CENTCOM

PROPER WAIVER AUTHORITY PRIOR TO DEPLOYMENT. CLINICAL FOLLOW-UP IN THEATER

SHOULD BE SOUGHT AT THE EARLIEST OPPORTUNITY TO OBTAIN MEDICATION RENEWALS.

mailto:USCENTAFSG.ORGBOX@AFCENT.AF.MIL mailto:USARMY.SHAW.USARCENT.MBX.SURG-WAIVER@MAIL.MIL mailto:FORCE.SURGEON@MARCENT.USMC.MIL mailto:CUSNC.MEDWAIVERS@ME.NAVY.MIL mailto:SOCCENT.SG@soccent.centcom.mil

15.D.3. PRESCRIPTION MEDICATION ANALYSIS AND REPORTING TOOL (PMART). SOLDIER

READINESS PROCESSING (SRP) AND OTHER DEPLOYMENT PLATFORM PROVIDER/PHARMACY

AND UNIT MEDICAL OFFICER PERSONNEL WILL MAXIMIZE THE USE OF THE PRESCRIPTION

MEDICATION ANALYSIS AND REPORTING TOOL (PMART) TO SCREEN DEPLOYING PERSONNEL

FOR HIGH-RISK MEDICATIONS, IDENTIFY MEDICATIONS NOT AVAILABLE ON THE CENTCOM

FORMULARY, AND OVER-THE-COUNTER AND TEMPERATURE-SENSITIVE MEDICATIONS NOT

AVAILABLE THROUGH THE MAIL ORDER PHARMACY. CONTACT THE DOD PHARMACY

OPERATIONS CENTER AT 1.866.275.4732 OR USARMY.JBSA.MEDCOM-

AMEDDCS.MBX.PHARMACOECONOMIC-CENTER@MAIL.MIL FOR INFORMATION ON HOW TO

OBTAIN A PMART REPORT. INFORMATION REGARDING PMART AS WELL AS THE CENTCOM

FORMULARY CAN BE FOUND AT THE DOD PHARMACOECONOMIC CENTER WEBSITE AT:

HTTP://PEC.HA.OSD.MIL/PMART/DEFAULT.PHP.

15.D.4. TRICARE MAIL ORDER PHARMACY (TMOP). PERSONNEL REQUIRING ONGOING

PHARMACOTHERAPY WILL MAXIMIZE USE OF THE TRICARE MAIL-ORDER PHARMACY (TMOP)

SYSTEM (TO INCLUDE MEDICATIONS LISTED IN 15.D.2.B AND 15.D.2.C) WHEN POSSIBLE.

THOSE ELIGIBLE FOR MOP WILL COMPLETE ON-LINE ENROLLMENT AND REGISTRATION PRIOR

TO DEPLOYMENT TO THE MAXIMUM EXTENT POSSIBLE. INSTRUCTIONS AND REGISTRATION

CAN BE FOUND AT HTTP://WWW.TRICARE.MIL/PHARMACY.ASPX.

15.E. MEDICAL EQUIPMENT.

15.E.1. PERMITTED EQUIPMENT. PERSONNEL WHO REQUIRE MEDICAL EQUIPMENT (E.G.,

CORRECTIVE EYEWEAR, HEARING AIDS) MUST DEPLOY WITH ALL REQUIRED ITEMS IN THEIR

POSSESSION TO INCLUDE TWO PAIRS OF EYEGLASSES, PROTECTIVE MASK EYEGLASS

INSERTS, BALLISTIC EYEWEAR INSERTS, AND HEARING AID BATTERIES. SEE REF C.

15.E.2. NON-PERMITTED EQUIPMENT. PERSONAL DURABLE MEDICAL EQUIPMENT

(NEBULIZERS, SCOOTERS, WHEELCHAIRS, CATHETERS, DIALYSIS MACHINES, ETC) IS NOT

PERMITTED. MEDICAL MAINTENANCE, LOGISTICAL SUPPORT, AND INFECTION CONTROL

PROTOCOLS FOR PERSONAL MEDICAL EQUIPMENT ARE NOT AVAILABLE AND ELECTRICITY IS

OFTEN UNRELIABLE. A WAIVER FOR A MEDICAL CONDITION REQUIRING PERSONAL DURABLE

MEDICAL EQUIPMENT WILL ALSO BE CONSIDERED APPLICABLE TO THE EQUIPMENT. DURABLE

MEDICAL EQUIPMENT THAT IS NOT MEDICALLY COMPULSORY BUT USED FOR RELIEF OR

MAINTENANCE OF A MEDICAL CONDITION WILL REQUIRE A WAIVER. MAINTENANCE AND

RESUPPLY OF NON-PERMITTED EQUIPMENT IS THE RESPONSIBILITY OF THE INDIVIDUAL.

15.E.3. CONTACT LENSES.

15.E.3.A. ARMY, NAVY AND MARINE PERSONNEL WILL NOT DEPLOY WITH CONTACT

LENSES EXCEPT IAW SERVICE POLICY.

15.E.3.B. AIR FORCE PERSONNEL (NON-AIRCREW) WILL NOT DEPLOY WITH CONTACT LENSES

UNLESS WRITTEN AUTHORIZATION IS PROVIDED BY THE DEPLOYING UNIT COMMANDER.

CONTACT LENSES ARE LIFE SUPPORT EQUIPMENT FOR USAF AIRCREWS AND THEREFORE

ARE EXEMPT IAW SERVICE GUIDELINES. AIR FORCE PERSONNEL DEPLOYING WITH CONTACT

LENSES MUST RECEIVE PRE-DEPLOYMENT EDUCATION IN THE SAFE WEAR AND

MAINTENANCE OF CONTACT LENSES IN THE DEPLOYED ENVIRONMENT. THEY MUST ALSO

DEPLOY WITH TWO PAIRS OF EYEGLASSES AND A SUPPLY OF CONTACT LENS MAINTENANCE

ITEMS (E.G., CLEANSING SOLUTION) ADEQUATE FOR THE DURATION OF THE DEPLOYMENT.

15.E.4. MEDICAL ALERT TAGS. DEPLOYING PERSONNEL REQUIRING MEDICAL ALERT TAGS

(E.G., MEDICATION ALLERGIES, G6PD DEFICIENCY) WILL DEPLOY WITH RED MEDICAL ALERT

TAGS WORN IN CONJUNCTION WITH THEIR PERSONAL IDENTIFICATION TAGS.

15.F. IMMUNIZATIONS.

15.F.1. ADMINISTRATION. ALL IMMUNIZATIONS WILL BE GIVEN IAW REF S. REFER TO THE

MILITARY VACCINE AGENCY WEBSITE HTTP://WWW.VACCINES.MIL OR CONTACT THE CENTCOM

mailto:USARMY.JBSA.MEDCOM-AMEDDCS.MBX.PHARMACOECONOMIC-CENTER@MAIL.MIL mailto:USARMY.JBSA.MEDCOM-AMEDDCS.MBX.PHARMACOECONOMIC-CENTER@MAIL.MIL http://pec.ha.osd.mil/PMART/DEFAULT.PHP http://www.tricare.mil/PHARMACY.ASPX http://www.vaccines.mil/

MILVAX REGIONAL ANALYST BRIAN.CANTERBURY2@CENTCOM.MIL FOR QUESTIONS AND

CLARIFICATIONS.

15.F.2. REQUIREMENTS. ALL PERSONNEL (TO INCLUDE PCS AND SHIPBOARD PERSONNEL)

TRAVELING FOR ANY PERIOD OF TIME TO THE THEATER WILL BE CURRENT WITH ADVISORY

COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) IMMUNIZATION GUIDELINES AND SERVICE

INDIVIDUAL MEDICAL READINESS (IMR) REQUIREMENTS IAW REF C. IN ADDITION, ALL TDY

PERSONNEL MUST COMPLY WITH THE FOREIGN CLEARANCE GUIDE FOR THE COUNTRIES TO

WHICH THEY ARE TRAVELING. MANDATORY VACCINES FOR DOD PERSONNEL (MILITARY,

CIVILIAN & CONTRACTORS) TRAVELING FOR ANY PERIOD OF TIME IN THEATER ARE:

15.F.2.A. TETANUS/DIPHTHERIA. RECEIVE A ONE-TIME DOSE OF TDAP IF NO PREVIOUS

DOSE(S) RECORDED. RECEIVE TETANUS TD IF ≥ 10 YEARS SINCE LAST TDAP OR TETANUS TD

BOOSTER.

15.F.2.B. VARICELLA. REQUIRED DOCUMENTATION OF ONE OF THE FOLLOWING: BORN

BEFORE 1980 (ASSUMED IMMUNITY EXCEPT FOR HEALTH CARE WORKERS), DOCUMENTED

HISTORY OF DISEASE BY THE PROVIDER WHO TREATED THE MEMBER AT THAT TIME (EITHER

BY AN EPIDEMIOLOGIC LINK OR LABORATORY CONFIRMATION), SUFFICIENT VARICELLA TITER, OR ADMINISTRATION OF VACCINE (2 DOSES). SEE REF II.

15.F.2.C. MEASLES / MUMPS / RUBELLA. IT IS TO BE ASSUMED THAT ALL INDIVIDUALS BORN

BEFORE 1957 ARE IMMUNE AND DO NOT REQUIRE THE IMMUNIZATIONS. DOCUMENTATION OF

IMMUNITY BY TITER OR IMMUNIZATION RECORDS OF 2 ADULT DOSES ARE REQUIRED FOR ALL

OTHER DEPLOYERS. IMMUNITY AGAINST MUMPS IS NOT NECESSARY AS A MILITARY

REQUIREMENT, BUT MAY BE APPROPRIATE IN EXCEPTIONAL CLINICAL CIRCUMSTANCES SUCH

AS OUTBREAKS.

15.F.2.D. POLIO-IPV. SINGLE ADULT BOOSTER IS REQUIRED FOR TRAVEL ONLY TO

AFGHANISTAN OR PAKISTAN. EITHER OPV OR IPV QUALIFY AS AN ADULT BOOSTER. IT IS TO

BE ASSUMED THAT ALL POST-ACCESSION MILITARY PERSONNEL ARE IMMUNE AND DO NOT

REQUIRE THIS BOOSTER. DOCUMENTATION OF IMMUNITY BY TITER OR IMMUNIZATION

RECORDS IS REQUIRED FOR ALL CIVILIAN DEPLOYERS.

15.F.2.E. SEASONAL INFLUENZA (INCLUDING EVENT-SPECIFIC INFLUENZA, E.G., H1N1).

15.F.2.F. HEPATITIS A. AT LEAST ONE DOSE PRIOR TO DEPLOYMENT WITH SUBSEQUENT

COMPLETION OF SERIES IN THEATER.

15.F.2.G. HEPATITIS B. AT LEAST ONE DOSE PRIOR TO DEPLOYMENT WITH SUBSEQUENT

COMPLETION OF SERIES IN THEATER.

15.F.2.H. TYPHOID. BOOSTER DOSE OF TYPHIM VI VACCINE IF GREATER THAN TWO YEARS

SINCE LAST VACCINATION WITH INACTIVATED / INJECTABLE VACCINE OR GREATER THAN FIVE YEARS SINCE RECEIPT OF LIVE / ORAL VACCINE. ORAL VACCINE (VIVOTIF) IS AN ACCEPTABLE

ALTERNATIVE IF TIME ALLOWS FOR RECEIPT AND COMPLETION OF ALL FOUR DOSES PRIOR TO

DEPLOYMENT.

15.F.3. ANTHRAX. PERSONNEL WITHOUT A MEDICAL CONTRAINDICATION TRAVELING IN THE

CENTCOM THEATER FOR 15 DAYS OR MORE WILL COMPLY WITH THE MOST CURRENT DOD

ANTHRAX REQUIREMENTS, CURRENTLY A SERIES OF 5 VACCINES AND ANNUAL BOOSTERS.

SEE REF N, T, U AND V AND EXCEPTIONS FOR VACCINATION IN 15.F.6.

15.F.3.A. MILITARY PERSONNEL. REQUIRED.

15.F.3.B. DOD CIVILIANS. REQUIRED AT GOVERNMENT EXPENSE, FOR EMERGENCY

ESSENTIAL PERSONNEL IAW REF T.

15.F.3.C. DOD CONTRACTORS. REQUIRED AT GOVERNMENT EXPENSE AS DIRECTED IN THE

CONTRACT.

15.F.3.D. VOLUNTEERS. VOLUNTARY AT GOVERNMENT EXPENSE.

mailto:BRIAN.CANTERBURY2@CENTCOM.MIL

15.F.4. SMALLPOX. PERSONNEL WITHOUT A MEDICAL CONTRAINDICATION TRAVELING IN THE

CENTCOM THEATER FOR 15 DAYS OR MORE WILL COMPLY WITH MOST CURRENT DOD

SMALLPOX REQUIREMENTS. WARNING: VARICELLA AND SMALLPOX VACCINATIONS MUST BE

GIVEN 28 DAYS APART TO DIFFERENTIATE BETWEEN POTENTIAL ADVERSE EVENTS. IF BOTH

ARE REQUIRED, VARICELLA VACCINE IS THE PRIORITY OVER SMALLPOX IN THE

PREDEPLOYMENT PHASE, AND THE SMALLPOX VACCINE SHOULD BE RECEIVED IN THEATER 28

DAYS LATER. SEE REF T, U AND W AND EXCEPTIONS FOR VACCINATION IN 15.F.6. ADDITIONAL

INFORMATION AVAILABLE AT HTTP://WWW.SMALLPOX.MIL.

15.F.4.A. MILITARY PERSONNEL. REQUIRED.

15.F.4.B. DOD CIVILIANS. REQUIRED.

15.F.4.C. DOD CONTRACTORS. REQUIRED AT GOVERNMENT EXPENSE.

15.F.4.D. VOLUNTEERS. VOLUNTARY AT GOVERNMENT EXPENSE.

15.F.4.E. MEDICAL TEMPORARY VACCINATION WAIVER. PERSONNEL HAVING A CLOSE

CONTACT WITH CONTRAINDICATIONS FOR THE SMALLPOX (VACCINIA) VACCINATION MAY BE

GIVEN UP TO A 30 DAY MEDICAL TEMPORARY WAIVER FOR SMALLPOX VACCINATION AND WILL

BE VACCINATED AT THE DEPLOYED LOCATION. INCLUDE THE SMALLPOX SCREENING

QUESTIONNAIRE AS PART OF THEIR DD FORM 2766, DEPLOYED MEDICAL RECORD AND EMR.

15.F.5. RABIES. FOR PRE-DEPLOYMENT PLANNING PURPOSES ONLY, RABIES PRE-EXPOSURE

VACCINATION SERIES MAY BE CONSIDERED FOR PERSONNEL WHO ARE NOT EXPECTED TO BE

ABLE TO RECEIVE PROMPT MEDICAL EVALUATION AND RISK-BASED RABIES POST-EXPOSURE

PROPHYLAXIS WITHIN 72 HOURS OF EXPOSURE TO A POTENTIALLY RABID ANIMAL. BOOSTER

DOSES ARE REQUIRED EVERY TWO YEARS OR WHEN TITERS INDICATE. EXCEPTIONS MAY BE

IDENTIFIED BY UNIT SURGEONS.

15.F.5.A. HIGH RISK PERSONNEL. PRE-EXPOSURE VACCINATION IS REQUIRED FOR

VETERINARY PERSONNEL, MILITARY WORKING DOG HANDLERS, ANIMAL CONTROL

PERSONNEL, CERTAIN SECURITY PERSONNEL, CIVIL ENGINEERS OCCUPATIONALLY AT RISK

OF EXPOSURE TO RABID ANIMALS, AND LABORATORY PERSONNEL WHO WORK WITH RABIES

SUSPECT SAMPLES.

15.F.5.B. SPECIAL OPERATIONS FORCES (SOF)/SOF ENABLERS. ALL PERSONNEL DEPLOYING

IN SUPPORT OF SOF WILL BE ADMINISTERED THE PRE-EXPOSURE RABIES VACCINE SERIES AS

INDICATED BELOW.

15.F.5.B.1. AFGHANISTAN. PERSONNEL WITH PRIMARY DUTIES OUTSIDE OF FIXED BASES.

15.F.5.B.2. PAKISTAN. ALL PERSONNEL.

15.F.5.B.3. OTHER AREAS. PER USSOCOM SERVICE-SPECIFIC POLICIES. CONTACT USSOCOM

PREVENTIVE MEDICINE OFFICER AT DSN (312) 299-5051 FOR MORE INFORMATION.

15.F.6. EXCEPTIONS. REQUIRED IMMUNIZATIONS WILL BE ADMINISTERED PRIOR TO

DEPLOYMENT, WITH THE FOLLOWING POSSIBLE EXCEPTIONS:

15.F.6.A. THE FIRST VACCINE IN A REQUIRED SERIES MUST BE ADMINISTERED PRIOR TO

DEPLOYMENT WITH ARRANGEMENTS MADE FOR SUBSEQUENT IMMUNIZATIONS TO BE GIVEN

IN THEATER.

15.F.6.B. IAW REF X, ANTHRAX AND SMALLPOX VACCINATIONS MAY BE ADMINISTERED UP TO

120 DAYS PRIOR TO DEPLOYMENT. IT IS HIGHLY ADVISABLE TO GET THE FIRST TWO ANTHRAX

IMMUNIZATIONS OR SUBSEQUENT DOSE/BOOSTER PRIOR TO DEPLOYMENT IN ORDER TO

AVOID UNNECESSARY STRAIN ON THE DEPLOYED HEALTHCARE SYSTEM.

15.F.7. ADVERSE MEDICAL EVENTS RELATED TO IMMUNIZATIONS SHOULD BE REPORTED

THROUGH REPORTABLE MEDICAL EVENTS (RME) IF CASE DEFINITIONS ARE MET. ALL

IMMUNIZATION RELATED UNEXPECTED ADVERSE EVENTS ARE TO BE REPORTED THROUGH

THE VACCINE ADVERSE EVENTS REPORTING SYSTEM (VAERS) AT

HTTP://WWW.VAERS.HHS.GOV.

http://www.smallpox.mil/ http://www.vaers.hhs.gov/

15.F.8. USCENTCOM AND COMPONENTS WILL MONITOR IMMUNIZATION COMPLIANCE VIA THE

COCOM IMMUNIZATION REPORTING DATABASE. SUBORDINATE COMMANDS WILL REQUEST

ACCESS TO THE COCOM IMMUNIZATION REPORTING DATABASE BY CONTACTING CCSG AT

BRIAN.CANTERBURY2@CENTCOM.MIL OR CCSG-PMO@CENTCOM.SMIL.MIL.

15.G. MEDICAL / LABORATORY TESTING.

15.G.1. HIV TESTING. HIV LAB TESTING, WITH DOCUMENTED NEGATIVE RESULT, WILL BE

WITHIN 120 DAYS PRIOR TO DEPLOYMENT OR DEPARTURE FOR ANY REQUIRED DEPLOYMENT

TRAINING IF TRAINING IS EN ROUTE TO DEPLOYMENT LOCATION. IAW REF Y, HIV INFECTION IS

A NON-DEPLOYABLE CONDITION.

15.G.2. SERUM SAMPLE. SAMPLE WILL BE TAKEN WITHIN THE PREVIOUS 365 DAYS. IF THE

INDIVIDUAL’S HEALTH STATUS HAS RECENTLY CHANGED OR HAS HAD AN ALTERATION IN

OCCUPATIONAL EXPOSURES THAT INCREASES HEALTH RISKS, A HEALTH CARE PROVIDER MAY

CHOOSE TO HAVE A SPECIMEN DRAWN CLOSER TO THE ACTUAL DATE OF DEPLOYMENT. SEE

REF Z.

15.G.3. G6PD TESTING. DOCUMENTATION OF ONE-TIME GLUCOSE-6-PHOSPHATE

DEHYDROGENASE (G6PD) DEFICIENCY TESTING IS IAW REF AA. ENSURE RESULT IS IN

MEDICAL RECORD OR DRAW PRIOR TO DEPARTURE. PRE-DEPLOYMENT MEDICAL SCREENERS

WILL RECORD THE RESULT OF THIS TEST IN THE SERVICE MEMBER'S PERMANENT MEDICAL

RECORD, DEPLOYMENT MEDICAL RECORD (DD FORM 2766) AND SERVICE SPECIFIC

ELECTRONIC MEDICAL RECORD. (REF AA DODI 6465.1) IF AN INDIVIDUAL IS FOUND TO BE

G6PD-DEFICIENT, THEY SHOULD BE ISSUED MEDICAL ALERT TAGS (RED DOG TAGS) THAT

STATE “G6PD DEFICIENT: NO PRIMAQUINE”. IF PRIMAQUINE IS GOING TO BE ISSUED TO A DOD

CIVILIAN OR DOD CONTRACTOR, COMPLETE THE TESTING AT GOVERNMENT EXPENSE.

15.G.4. HCG. REQUIRED WITHIN 30 DAYS OF DEPLOYMENT FOR ALL WOMEN. THOSE WOMEN

WITH A DOCUMENTED HISTORY OF A HYSTERECTOMY ARE EXEMPT. PREGNANCY WILL BE

RULED OUT PRIOR TO ANY IMMUNIZATION (EXCEPT INFLUENZA) AND MEDICAL CLEARANCE

FOR DEPLOYMENT.

15.G.5. DNA SAMPLE. REQUIRED FOR ALL DOD PERSONNEL, INCLUDING CIVILIANS AND

CONTRACTORS. OBTAIN SAMPLE OR CONFIRM SAMPLE IS ON FILE BY CONTACTING THE DOD

DNA SPECIMEN REPOSITORY (COMM: 301.319.0366, DSN: 285; FAX 301.319.0369);

HTTP://WWW.AFMES.MIL . SEE REF C AND BB.

15.G.6. TUBERCULOSIS (TB) TESTING.

15.G.6.A. TUBERCULOSIS TESTING FOR SERVICE MEMBERS WILL BE PERFORMED AND

DOCUMENTED IAW CURRENT SERVICE POLICY. DOD CIVILIANS, CONTRACTORS, VOLUNTEERS

AND OTHER PERSONNEL WILL BE TESTED FOR TB WITHIN 90 DAYS OF DEPLOYMENT IAW REF J

AND CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) GUIDELINES. ONE PURPOSE

OF SUCH TESTING IS TO RULE OUT PREVIOUSLY UNIDENTIFIED LATENT TB INFECTION (LTBI) IN

ORDER TO ENSURE ADEQUATE TREATMENT WAS EITHER COMPLETED OR OFFERED. THE

OTHER PURPOSE IS TO DOCUMENT A NEGATIVE TEST IN ORDER TO DETECT NEW INFECTION

FROM TRANSMISSION DURING DEPLOYMENT. IF TESTING IS PERFORMED, TUBERSOL® BRAND

TUBERCULIN SKIN TEST (TST) IS PREFERRED. IN THE EVENT OF A TUBERSOL® SHORTAGE,

APLISOL® BRAND TST OR AN INTERFERON-GAMMA RELEASE ASSAY (IGRA, I.E.,

QUANTIFERON® GOLD IN TUBE OR THE T-SPOT® TB) MAY BE USED.

15.G.6.B. POSITIVE TB TESTS WILL BE HANDLED IAW SERVICE POLICY AND CDC GUIDELINES.

PERSONNEL WITH A POSITIVE TB TEST SHOULD BE EVALUATED AND COUNSELED. THIS

EVALUATION WILL INCLUDE AT LEAST A SYMPTOM QUESTIONNAIRE FOR TB DISEASE,

EXPOSURE HISTORY AND CHEST X-RAY.

15.G.6.C. THE DECISION TO TREAT LTBI IN U.S. FORCES AND CIVILIANS DURING DEPLOYMENT

INSTEAD OF AFTER REDEPLOYMENT SHOULD INCLUDE CONSIDERATION OF THE RISKS AND

mailto:BRIAN.CANTERBURY2@CENTCOM.MIL mailto:CCSG-PMO@CENTCOM.SMIL.MIL http://www.afmes.mil/

BENEFITS OF TREATMENT DURING DEPLOYMENT, INCLUDING: RISK OF ACTIVATION OF TB,

RISK OF ADVERSE EVENTS FROM LTBI TREATMENT, TIME REMAINING IN DEPLOYMENT,

AVAILABILITY OF MEDICAL PERSONNEL TRAINED IN LTBI TREATMENT, AVAILABILITY OF

FOLLOW-UP DURING TREATMENT, AND AVAILABILITY OF MEDICATION. LACK OF TREATMENT

FOR LTBI IS NOT A CONTRAINDICATION FOR DEPLOYMENT INTO THE CENTCOM AOR AND NO

WAIVERS ARE REQUIRED FOR A DIAGNOSIS OF LTBI IF APPROPRIATE EVALUATION AND

COUNSELING, AS NOTED ABOVE, IS COMPLETED.

15.G.6.D. UNIT-BASED / LARGE GROUP OR INDIVIDUAL LTBI TESTING SHOULD NOT BE

PERFORMED IN THE AOR EXCEPT AMONG CLOSE CONTACTS OF CASES OF KNOWN TB

DISEASE.

15.G.6.E. U.S. FORCES AND DOD CIVILIANS WITH TB DISEASE WILL BE EVACUATED FROM

THEATER FOR DEFINITIVE TREATMENT. EVALUATION AND TREATMENT OF TB AMONG U.S.

CONTRACTORS, LOCAL NATIONALS (LN) AND THIRD COUNTRY NATIONAL (TCN) EMPLOYEES

WILL BE AT CONTRACTOR EXPENSE. EMPLOYEES WITH SUSPECTED OR CONFIRMED

PULMONARY TB DISEASE WILL BE EXCLUDED FROM WORK UNTIL CLEARED BY THE THEATER

PREVENTIVE MEDICINE CONSULTANT FOR RETURN TO WORK.

15.G.7. OTHER LABORATORY TESTING. OTHER TESTING MAY BE PERFORMED AT THE

CLINICIAN’S DISCRETION COMMENSURATE WITH RULING OUT NON-DEPLOYABLE CONDITIONS

AND ENSURING PERSONNEL MEET STANDARDS OF FITNESS IAW PARAGRAPH 15.C.2.

15.H. HEALTH ASSESSMENTS.

15.H.1. HEALTH ASSESSMENTS AND EXAMS. PERIODIC HEALTH ASSESSMENTS MUST BE

CURRENT IAW SERVICE POLICY AT TIME OF DEPLOYMENT AND SPECIAL DUTY EXAMS MUST BE

CURRENT FOR THE DURATION OF TRAVEL OR DEPLOYMENT PERIOD. SEE REF C, J.

15.H.2. PRE-DEPLOYMENT HEALTH ASSESSMENT (DD FORM 2795).

15.H.2.A. ALL DOD PERSONNEL (MILITARY, CIVILIAN, CONTRACTOR) TRAVELING TO THE

THEATER FOR MORE THAN 30 DAYS WILL COMPLETE OR CONFIRM AS CURRENT A PRE-

DEPLOYMENT HEALTH ASSESSMENT WITHIN 120 DAYS OF THE EXPECTED DEPLOYMENT DATE

IAW REF R. THIS ASSESSMENT WILL BE COMPLETED ON A DD FORM 2795 IAW DODI 6490.03.

THIS DOES NOT APPLY TO PCS PERSONNEL, SHIPBOARD PERSONNEL OR PERSONNEL

LOCATED WITH A DHP FUNDED FIXED MEDICAL TREATMENT FACILITY (E.G. BAHRAIN) IAW REF C.

15.H.2.A.1. PERSONNEL TRAVELING TO THE THEATER FOR 15 OR MORE DAYS BUT LESS THAN

30 DAYS ARE ENCOURAGED TO COMPLETE A PRE-DEPLOYMENT HEALTH ASSESSMENT IN

ORDER TO DOCUMENT THEIR HEALTH STATUS AND ADDRESS ANY HEALTH CONCERNS PRIOR

TO TRAVEL TO THEATER. THIS IS ESPECIALLY RELEVANT TO THOSE WHOSE POSITION

REQUIRES FREQUENT TRAVEL TO THE AOR. THESE INDIVIDUALS ARE ENCOURAGED TO

COMPLETE AT LEAST ONE PRE-DEPLOYMENT HEALTH ASSESSMENT EACH YEAR, ALONG WITH

A CORRESPONDING POST-DEPLOYMENT HEALTH ASSESSMENT FOR THE SAME YEAR.

15.H.2.B. FOLLOWING COMPLETION OF THE DD FORM 2795, A TRAINED HEALTH CARE

PROVIDER (NURSE, MEDICAL TECHNICIAN, MEDIC OR CORPSMAN) WILL IMMEDIATELY REVIEW

IT. POSITIVE RESPONSES TO QUESTIONS 2, 4, 5 OR 8 (ON THE UPDATED DD FORM 2795)

REQUIRES REFERRAL TO AN INDEPENDENT PRACTITIONER (PHYSICIAN, PHYSICIAN

ASSISTANT, NURSE PRACTITIONER, ADVANCED PRACTICE NURSE, INDEPENDENT DUTY

CORPSMAN, INDEPENDENT DUTY MEDICAL TECHNICIAN, OR SPECIAL FORCES MEDICAL

SERGEANT).

15.H.2.C. THE COMPLETED ORIGINAL DD FORM 2795 WILL BE PLACED IN THE DEPLOYING

PERSON'S PERMANENT MEDICAL RECORD, A PAPER COPY IN THE DEPLOYMENT MEDICAL

RECORD (DD FORM 2766), AND TRANSMIT AN ELECTRONIC COPY TO THE DEFENSE MEDICAL

SURVEILLANCE SYSTEM (DMSS) AT THE ARMED FORCES HEALTH SURVEILLANCE CENTER

(AFHSC). CONTRACT PERSONNEL ARE NOT REQUIRED TO ELECTRONICALLY SUBMIT THE DD

FORM 2795; A PAPER VERSION WILL SUFFICE.

15.H.3. AUTOMATED NEUROPSYCHOLOGICAL ASSESSMENT METRIC (ANAM).

ALL SERVICE MEMBERS AS DESIGNATED IN REF FF AT

HTTP://WWW.DTIC.MIL/WHS/DIRECTIVES/CORRES/PDF/649013P.PDF WILL UNDERGO ANAM

TESTING WITHIN 12 MONTHS PRIOR TO DEPLOYMENT. ANAM TESTING WILL BE RECORDED IN

APPROPRIATE SERVICE DATABASE AND ELECTRONIC MEDICAL RECORD. CONTRACTORS, PCS

AND SHIPBOARD PERSONNEL ARE NOT REQUIRED TO UNDERGO ANAM TESTING.

15.H.4. POST-DEPLOYMENT HEALTH ASSESSMENT (DD FORM 2796).

15.H.4.A. ALL PERSONNEL WHO WERE REQUIRED TO COMPLETE A PRE-DEPLOYMENT HEALTH

ASSESSMENT WILL COMPLETE A POST-DEPLOYMENT HEALTH ASSESSMENT ON A DD FORM

2796. THE POST-DEPLOYMENT HEALTH ASSESSMENT MUST BE COMPLETED NO EARLIER THAN

30 DAYS BEFORE EXPECTED REDEPLOYMENT DATE AND NO LATER THAN 30 DAYS AFTER

REDEPLOYMENT.

15.H.4.A.1. INDIVIDUALS WHO WERE NOT REQUIRED TO COMPLETE A PRE-DEPLOYMENT

HEALTH ASSESSMENT, BUT WHO COMPLETED ONE TO COVER MULTIPLE TRIPS TO THEATER

EACH OF 30 DAYS OR LESS DURATION, SHOULD COMPLETE A POST-DEPLOYMENT HEALTH

ASSESSMENT AT LEAST ONCE A YEAR TO DOCUMENT ANY POTENTIAL EXPOSURES OF

CONCERN RESULTING FROM ANY SUCH TRAVEL AND THE POTENTIAL NEED FOR MEDICAL

FOLLOW-UP.

15.H.4.B. ALL REDEPLOYING PERSONNEL WILL UNDERGO A PERSON-TO-PERSON HEALTH

ASSESSMENT WITH AN INDEPENDENT PRACTITIONER. THE ORIGINAL COMPLETED COPY OF

THE DD FORM 2796 MUST BE PLACED IN THE INDIVIDUAL'S MEDICAL RECORD AND TRANSMIT

AN ELECTRONIC COPY TO THE DMSS AT THE AFHSC. CONTRACT PERSONNEL ARE NOT

REQUIRED TO ELECTRONICALLY SUBMIT THE DD FORM 2796; A PAPER VERSION WILL SUFFICE.

15.H.5. MENTAL HEALTH ASSESSMENT. ALL SERVICE MEMBERS WILL UNDERGO A PERSON-

TO-PERSON MENTAL HEALTH ASSESSMENT WITH A LICENSED MENTAL HEALTH PROFESSIONAL

OR TRAINED AND CERTIFIED HEALTH CARE PERSONNEL (SPECIFICALLY A PHYSICIAN,

PHYSICIAN ASSISTANT, NURSE PRACTITIONER, ADVANCED

PRACTICE NURSE, INDEPENDENT DUTY CORPSMAN, SPECIAL FORCES MEDICAL SERGEANT,

INDEPENDENT DUTY MEDICAL TECHNICIAN OR INDEPENDENT HEALTH SERVICES

TECHNICIAN). TO ENSURE CONSISTENCY OF THESE ASSESSMENTS, MANDATORY SELF-

DIRECTED TRAINING FOR DEPLOYMENT MENTAL HEALTH ASSESSMENTS IS AVAILABLE AT:

HTTP://FHPR.OSD.MIL/MENTALHEALTHASSESSMENT. THESE ASSESSMENTS WILL BE

ACCOMPLISHED WITHIN 120 DAYS PRIOR TO DEPLOYMENT AND WITHIN 3 TIMEFRAMES (3-6, 7-

18, AND 18-30 MONTHS) AFTER REDEPLOYMENT. THESE MENTAL HEALTH ASSESSMENTS WILL

BE ADMINISTERED AT LEAST 90 DAYS APART. CURRENTLY ADMINISTERED PERIODIC AND

OTHER PERSON-TO-PERSON HEALTH ASSESSMENTS, SUCH AS THE POST-DEPLOYMENT

HEALTH REASSESSMENT, WILL MEET THE TIME REQUIREMENTS IF THEY CONTAIN ALL

PSYCHOLOGICAL AND SOCIAL QUESTIONS IAW REF P.

15.H.5.A. THIS DOES NOT DIRECTLY APPLY TO DOD CONTRACTORS UNLESS SPECIFIED IN THE

CONTRACT OR THERE IS A CONCERN FOR A MENTAL HEALTH ISSUE. ALL RELATED MENTAL

HEALTH EVALUATIONS WILL BE AT THE CONTRACTOR’S EXPENSE.

15.H.6. POST-DEPLOYMENT HEALTH RE-ASSESSMENT (DD FORM 2900). ALL PERSONNEL WHO

WERE REQUIRED TO COMPLETE A PRE- AND POST-DEPLOYMENT HEALTH ASSESSMENT WILL

COMPLETE A POST-DEPLOYMENT HEALTH REASSESSMENT (DD FORM 2900) 90 TO 180 DAYS

AFTER RETURN TO HOME STATION. SEE WWW.PDHEALTH.MIL FOR ADDITIONAL INFORMATION

ON PRE- AND POST-DEPLOYMENT HEALTH ASSESSMENTS. CONTRACT PERSONNEL ARE NOT

REQUIRED TO ELECTRONICALLY SUBMIT THE DD FORM 2900; A PAPER VERSION WILL SUFFICE.

http://www.dtic.mil/WHS/DIRECTIVES/CORRES/PDF/649013P.PDF http://fhpr.osd.mil/MENTALHEALTHASSESSMENT http://www.pdhealth.mil/

15.I. MEDICAL RECORD. SEE REF C.

15.I.1. DEPLOYED MEDICAL RECORD. THE DD FORM 2766, ADULT PREVENTIVE AND CHRONIC

CARE FLOWSHEET, OR EQUIVALENT, WILL BE USED INSTEAD OF DEPLOYING AN INDIVIDUAL’S

ENTIRE MEDICAL RECORD.

15.I.1.A. DEPLOYED PERSONNEL (MORE THAN 30 DAYS). DD2766 IS REQUIRED.

15.I.1.B. TDY PERSONNEL (15 – 30 DAYS). DD FORM 2766 IS HIGHLY ENCOURAGED,

ESPECIALLY FOR THOSE WHO TRAVEL FREQUENTLY TO THEATER, TO DOCUMENT THEATER-

SPECIFIC VACCINES AND CHEMOPROPHYLAXIS, AS REQUIRED.

15.I.1.C. TDY PERSONNEL (LESS THAN 15 DAYS). DD2766 IS NOT REQUIRED.

15.I.1.D. PCS PERSONNEL. FOLLOW SERVICE GUIDELINES FOR MEDICAL RECORD

MANAGEMENT.

15.I.2. MEDICAL INFORMATION. THE FOLLOWING HEALTH INFORMATION MUST BE PART OF AN

ACCESSIBLE ELECTRONIC MEDICAL RECORD FOR ALL PERSONNEL (SERVICE MEMBERS,

CIVILIANS AND CONTRACTORS), OR BE HAND-CARRIED AS PART OF A DEPLOYED MEDICAL

RECORD:

15.I.2.A. ANNOTATION OF BLOOD TYPE AND RH FACTOR, G6PD, HIV, AND DNA.

15.I.2.B. CURRENT MEDICATIONS AND ALLERGIES. INCLUDE ANY FORCE HEALTH PROTECTION

PRESCRIPTION PRODUCT (FHPPP) PRESCRIBED AND DISPENSED TO AN INDIVIDUAL.

15.I.2.C. SPECIAL DUTY QUALIFICATIONS.

15.I.2.D. ANNOTATION OF CORRECTIVE LENS PRESCRIPTION.

15.I.2.E. SUMMARY SHEET OF CURRENT AND PAST MEDICAL AND SURGICAL CONDITIONS.

15.I.2.F. MOST RECENT DD FORM 2795, PREDEPLOYMENT HEALTH ASSESSMENT.

15.I.2.G. DOCUMENTATION OF DENTAL STATUS CLASSES I OR CLASS II.

15.I.2.H. IMMUNIZATION RECORD. MEDICAL DEPLOYMENT SITES WILL ENTER IMMUNIZATION

DATA INTO SERVICE ELECTRONIC TRACKING SYSTEMS, (ARMY-MEDPROS, AIR FORCE-AFCITA,

COAST GUARD-MRRS, NAVY-MRRS (ASHORE) OR SAMS (AFLOAT) AND MARINE CORPS-MRRS).

DEPLOYMENT SITES WILL NOT ENTER DOD CONTRACTOR IMMUNIZATION DATA INTO THE

MEDICAL HEALTH SYSTEM RESOURCE UNLESS THEY ARE AUTHORIZED DOD MEMBERS (I.E.

RETIRED, DEPENDENTS, GUARD OR RESERVE).

15.I.2.I. ALL APPROVED MEDICAL WAIVERS.

15.J. PRE-DEPLOYMENT TRAINING. SEE REF C.

15.J.1. SCOPE. GENERAL ISSUES TO BE ADDRESSED. INFORMATION REGARDING KNOWN AND

SUSPECTED HEALTH RISKS AND EXPOSURES, HEALTH RISK COUNTERMEASURES AND THEIR

PROPER EMPLOYMENT, PLANNED ENVIRONMENTAL AND OCCUPATIONAL SURVEILLANCE

MONITORING, AND THE OVERALL OPERATIONAL RISK MANAGEMENT PROGRAM.

15.J.2. CONTENT. SHOULD INCLUDE, BUT NOT BE LIMITED TO, THE FOLLOWING AREAS:

COMBAT/OPERATIONAL STRESS CONTROL AND RESILIENCE; POST-TRAUMATIC STRESS AND

SUICIDE PREVENTION; MILD TRAUMATIC BRAIN INJURY RISK, IDENTIFICATION AND TRACKING;

NUCLEAR, BIOLOGICAL, CHEMICAL THREATS; ENDEMIC PLANT, ANIMAL, REPTILE AND INSECT

HAZARDS AND INFECTIONS; COMMUNICABLE DISEASES; VECTORBORNE DISEASES;

ENVIRONMENTAL CONDITIONS; SAFETY; OCCUPATIONAL HEALTH.

15.K. MEDICAL CBRN DEFENSE MATERIEL (MCDM) / CHEMICAL BIOLOGICAL RADIOLOGICAL

NUCLEAR (CBRN) RESPONSE.

15.K.1. MCDM ITEMS. TO PROTECT AGAINST CBRN THREATS WITHIN THE AOR, DEPLOYING

UNITS WILL ENSURE THE AVAILABILITY OF THE FOLLOWING TYPES AND QUANTITIES OF MCDM

ITEMS FOR ALL DEPLOYERS. CONTRACTORS WILL RECEIVE THESE ITEMS PER THEIR

CONTRACT.

15.K.1.A. ANTIDOTE TREATMENT NERVE AGENT AUTOINJECTOR (ATNAA) (6505-01-362-7427);

THREE EACH PER DEPLOYING INDIVIDUAL.

15.K.1.B. DIAZEPAM INJECTION (CONVULSANT ANTIDOTE NERVE AGENT - CANA) (6505-01-274-

0951); ONE EACH PER DEPLOYING INDIVIDUAL.

15.K.1.C. M291A SKIN DECONTAMINATION KIT OR REACTIVE SKIN DECONTAMINATION LOTION

(RSDL). ONE M291A KIT OR ONE POUCH CONTAINING 3 PACKETS OF RSDL PER DEPLOYING

INDIVIDUAL.

15.K.1.D. DEPLOYING UNITS WILL PROVIDE MEMBERS WITH EITHER CIPROFLOXIN 500MG TABS

OR DOXYCYCLINE 100MG TABS; SIX TABS (BLISTER PACKS PREFERABLE) PER DEPLOYING

INDIVIDUAL OF EITHER MEDICATION (REGARDLESS OF CHOICE, ENSURE ADEQUATE SUPPLY

OF SECOND MEDICATION TO ACCOMMODATE INTOLERANCE TO THE DRUG OF FIRST CHOICE).

THIS COVERS AN INITIAL DOSAGE TO SUPPORT PROPHYLAXIS AND/OR TREATMENT FOR

THREE DAYS PER INDIVIDUAL. THIS DOES NOT PRECLUDE UNITS FROM HAVING THE

REMAINING STOCKS ON HAND TO COMPLETE A 30 DAY COURSE OF MEDICATION (60 TABLETS)

AND UNITS SHOULD PLAN ACCORDINGLY GIVEN MISSION REQUIREMENTS. ADDITIONALLY,

THOSE INDIVIDUALS USING DOXYCYCLINE FOR MALARIA PROPHYLAXIS MAY BE CONSIDERED

TO BE COVERED FOR THESE REMAINING DOSES.

15.K.1.E. INDIVIDUAL DEPLOYERS RECEIVING MCDM ITEMS DURING PRE-DEPLOYMENT

PROCESSING WILL TURN IN THESE ITEMS TO THEIR UNIT UPON ARRIVAL IN THE AOR.

15.K.2. CBRN COUNTERMEASURES.

15.K.2.A. TO PROTECT AGAINST POSSIBLE AND POTENTIALLY INDICATED CBRN THREATS

WITHIN THE AOR, SERVICE COMPONENTS WILL BPT ACQUIRE AND ISSUE, IAW SERVICE POLICY

OR ON ORDER FROM THE CENTCOM COMMANDER, THE FOLLOWING TYPES AND QUANTITIES

OF MCDM ITEMS FOR THEIR IN-THEATER FORCES.

15.K.2.B. PYRIDOSTIGMINE BROMIDE (PB) 30MG TABS (SOMAN NERVE AGENT PRETREATMENT

PYRIDOSTIGMINE - SNAPP); 42 TABLETS PER DEPLOYED INDIVIDUAL.

15.K.2.B.1. POTASSIUM IODIDE (KI) TABLETS (FOR BETA/GAMMA RADIATION EXPOSURE); 14

TABS PER DEPLOYED INDIVIDUAL.

15.K.2.B.2. SERVICE COMPONENTS AND/OR JTFS WITH BASE OPERATING SUPPORT (BOS)

RESPONSIBILITY FOR BASES IN THEATER THAT ARE KEY TRANSPORTATION AND SUPPORT

NODES WILL ENSURE ADEQUATE AMOUNTS OF THE MCDM ITEMS LISTED IN PARAGRAPH 15.K.

ARE PRE-POSITIONED AND STORED TO SUPPORT THE TRANSIENT POPULATION (NON

DEPLOYERS, PCS PERSONNEL, ETC.) THAT MAY…